Our findings that only polymorphisms in the rs1801725 SNP of the receptor are associated with higher calcium levels suggest that mutations in codon 986 in exon 7 of the CASR are associated with BC outcomes driven by higher than normal circulating calcium levels such as larger and more aggressive breast tumors. This evidence concerns the gene CASR and breast neoplasm.